343 related articles for article (PubMed ID: 17369521)
1. Loss of stearoyl-CoA desaturase-1 improves insulin sensitivity in lean mice but worsens diabetes in leptin-deficient obese mice.
Flowers JB; Rabaglia ME; Schueler KL; Flowers MT; Lan H; Keller MP; Ntambi JM; Attie AD
Diabetes; 2007 May; 56(5):1228-39. PubMed ID: 17369521
[TBL] [Abstract][Full Text] [Related]
2. Stearoyl-CoA desaturase-1 deficiency attenuates obesity and insulin resistance in leptin-resistant obese mice.
Miyazaki M; Sampath H; Liu X; Flowers MT; Chu K; Dobrzyn A; Ntambi JM
Biochem Biophys Res Commun; 2009 Mar; 380(4):818-22. PubMed ID: 19338759
[TBL] [Abstract][Full Text] [Related]
3. Leptin suppresses stearoyl-CoA desaturase 1 by mechanisms independent of insulin and sterol regulatory element-binding protein-1c.
Biddinger SB; Miyazaki M; Boucher J; Ntambi JM; Kahn CR
Diabetes; 2006 Jul; 55(7):2032-41. PubMed ID: 16804073
[TBL] [Abstract][Full Text] [Related]
4. Loss of stearoyl-CoA desaturase 1 rescues cardiac function in obese leptin-deficient mice.
Dobrzyn P; Dobrzyn A; Miyazaki M; Ntambi JM
J Lipid Res; 2010 Aug; 51(8):2202-10. PubMed ID: 20363835
[TBL] [Abstract][Full Text] [Related]
5. Stearoyl-CoA desaturase deficiency, hypercholesterolaemia, cholestasis and diabetes.
Attie AD; Flowers MT; Flowers JB; Groen AK; Kuipers F; Ntambi JM
Novartis Found Symp; 2007; 286():47-53; discussion 54-7, 162-3, 196-203. PubMed ID: 18269173
[TBL] [Abstract][Full Text] [Related]
6. Stearoyl-CoA desaturase--a new player in skeletal muscle metabolism regulation.
Dobrzyń A; Dobrzyń P
J Physiol Pharmacol; 2006 Nov; 57 Suppl 10():31-42. PubMed ID: 17242489
[TBL] [Abstract][Full Text] [Related]
7. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
8. Stearoyl-CoA desaturase-1 deficiency reduces ceramide synthesis by downregulating serine palmitoyltransferase and increasing beta-oxidation in skeletal muscle.
Dobrzyn A; Dobrzyn P; Lee SH; Miyazaki M; Cohen P; Asilmaz E; Hardie DG; Friedman JM; Ntambi JM
Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E599-607. PubMed ID: 15562249
[TBL] [Abstract][Full Text] [Related]
9. Hepatic stearoyl CoA desaturase 1 deficiency increases glucose uptake in adipose tissue partially through the PGC-1α-FGF21 axis in mice.
Aljohani A; Khan MI; Bonneville A; Guo C; Jeffery J; O'Neill L; Syed DN; Lewis SA; Burhans M; Mukhtar H; Ntambi JM
J Biol Chem; 2019 Dec; 294(51):19475-19485. PubMed ID: 31690632
[TBL] [Abstract][Full Text] [Related]
10. Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity.
Ntambi JM; Miyazaki M; Stoehr JP; Lan H; Kendziorski CM; Yandell BS; Song Y; Cohen P; Friedman JM; Attie AD
Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11482-6. PubMed ID: 12177411
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of hepatic stearoyl-CoA desaturase-1 expression by fucoxanthin via leptin signaling in diabetic/obese KK-A(y) mice.
Beppu F; Hosokawa M; Yim MJ; Shinoda T; Miyashita K
Lipids; 2013 May; 48(5):449-55. PubMed ID: 23516000
[TBL] [Abstract][Full Text] [Related]
12. Loss of stearoyl-CoA desaturase 1 inhibits fatty acid oxidation and increases glucose utilization in the heart.
Dobrzyn P; Sampath H; Dobrzyn A; Miyazaki M; Ntambi JM
Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E357-64. PubMed ID: 18042664
[TBL] [Abstract][Full Text] [Related]
13. Stearoyl-CoA desaturase as a new drug target for obesity treatment.
Dobrzyn A; Ntambi JM
Obes Rev; 2005 May; 6(2):169-74. PubMed ID: 15836467
[TBL] [Abstract][Full Text] [Related]
14. Abnormally decreased NO and augmented CO production in islets of the leptin-deficient ob/ob mouse might contribute to explain hyperinsulinemia and islet survival in leptin-resistant type 2 obese diabetes.
Jimenez-Feltstrom J; Salehi A; Meidute Abaraviciene S; Henningsson R; Lundquist I
Regul Pept; 2011 Oct; 170(1-3):43-51. PubMed ID: 21620903
[TBL] [Abstract][Full Text] [Related]
15. The role of stearoyl-CoA desaturase in body weight regulation.
Dobrzyn A; Ntambi JM
Trends Cardiovasc Med; 2004 Feb; 14(2):77-81. PubMed ID: 15030794
[TBL] [Abstract][Full Text] [Related]
16. Hepatic CCAAT/enhancer binding protein alpha mediates induction of lipogenesis and regulation of glucose homeostasis in leptin-deficient mice.
Matsusue K; Gavrilova O; Lambert G; Brewer HB; Ward JM; Inoue Y; LeRoith D; Gonzalez FJ
Mol Endocrinol; 2004 Nov; 18(11):2751-64. PubMed ID: 15319454
[TBL] [Abstract][Full Text] [Related]
17. Recent insights into stearoyl-CoA desaturase-1.
Ntambi JM; Miyazaki M
Curr Opin Lipidol; 2003 Jun; 14(3):255-61. PubMed ID: 12840656
[TBL] [Abstract][Full Text] [Related]
18. Gene expression profiling in skeletal muscle of Zucker diabetic fatty rats: implications for a role of stearoyl-CoA desaturase 1 in insulin resistance.
Voss MD; Beha A; Tennagels N; Tschank G; Herling AW; Quint M; Gerl M; Metz-Weidmann C; Haun G; Korn M
Diabetologia; 2005 Dec; 48(12):2622-30. PubMed ID: 16284748
[TBL] [Abstract][Full Text] [Related]
19. Stearoyl-CoA desaturase-1 and the metabolic syndrome.
Cohen P; Ntambi JM; Friedman JM
Curr Drug Targets Immune Endocr Metabol Disord; 2003 Dec; 3(4):271-80. PubMed ID: 14683458
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of murine SCD4, a novel heart-specific stearoyl-CoA desaturase isoform regulated by leptin and dietary factors.
Miyazaki M; Jacobson MJ; Man WC; Cohen P; Asilmaz E; Friedman JM; Ntambi JM
J Biol Chem; 2003 Sep; 278(36):33904-11. PubMed ID: 12815040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
